Search

Search Constraints

You searched for: Author/Creator Bertheussen, Heidi

Search Results

1. 2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19. Issue 1 (7th October 2021)

2. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Issue 6 (30th April 2014)

3. EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19. Issue 6 (5th February 2021)

4. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Issue 6 (20th May 2020)

5. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus‐Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis. Issue 3 (6th February 2018)

6. Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative. Issue 6 (16th March 2016)